P5 Health Ventures

P5 Health Ventures is a venture capital firm based in Fairfield, Connecticut, specializing in the rapidly growing digital health sector in the United States. Founded in 2015, the firm focuses on investing in early to mid-stage digital health and care technology companies that aim to improve human life while generating societal benefits and financial returns. Their investment strategy centers on software platform-driven companies that integrate devices and services directly with consumers, collecting valuable data to enhance healthcare delivery.

The firm primarily invests in companies near or well into revenue generation, with a focus on Seed to Series B stages, typically investing up to $1 million in Seed rounds and up to $3.5 million in Series A/B rounds, with co-investment opportunities. Their areas of interest include patient signal platforms, disease management, consumer-driven healthcare, population health management, diagnostics, telehealth, remote monitoring, and technologies that drive down the costs of care while improving quality and accessibility.

P5 Health Ventures believes that digitization enables insights, consistent quality, precision, affordability, and accessibility, thereby democratizing health and care for all. The firm has invested in several companies, including Genialis, Bindle, Clarapath, FIGUR8, Hawthorne Effect, Iterative Health, Conversa, and CoreMap, reflecting its commitment to advancing healthcare through innovative technology solutions.